Cover Image
Market Research Report
Product code 
1031063

Biomaterials Market - A Global and Regional Analysis: Focus on Applications, Product Types, and Countries - Analysis and Forecast, 2021-2031

Published: | BIS Research Inc. | 266 Pages | Delivery time: 1-2 business days

Price

Back to Top
Biomaterials Market - A Global and Regional Analysis: Focus on Applications, Product Types, and Countries - Analysis and Forecast, 2021-2031
Published: September 30, 2021
BIS Research Inc.
Content info: 266 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

“Global Biomaterials Market is Expected to Reach $725.88 Billion by 2031.”

Market Report Coverage - Biomaterials Market

Market Segmentation

  • Application: Cardiovascular, Orthopedic, Ophthalmology, Dental, Wound Healing, Plastic Surgery, Neurological/Central Nervous System, Tissue Engineering, and Others
  • Product Type: Metal-Based Biomaterials, Polymer-Based Biomaterials, Ceramic-Based Biomaterials, Natural-Based Biomaterials, Inorganic Glass-Based Biomaterials, Radiopaque Biomaterials, Regenerative Biomaterials, and Hybrid Biomaterial Combinations

Regional Segmentation

  • North America: U.S., Canada, and Mexico
  • Europe: France, Germany, Spain, Italy, Russia, and Rest-of-Europe
  • Asia-Pacific: Japan, India, South Korea, and Rest-of-Asia-Pacific
  • China
  • U.K.
  • Rest-of-the-World: South America and Middle East and Africa

Market Growth Drivers

  • Increasing Funds/Aids by Government for Research Purposes
  • Increasing Plastic Surgery and Wound Healing Therapies
  • Increasing Aging/Geriatric Population
  • Rise in Prevalence of Cardiovascular Diseases
  • Increasing Orthopedic Disorders
  • Growing Demand for Implantable Devices
  • Increasing Awareness of Regenerative Medicine

Market Challenges

  • Biocompatibility Issues and Safety and Stringent Regulations
  • Limitations of Biomaterial-Based Products

Market Opportunities

  • Increasing Obesity
  • Patient Awareness and Improved Lifestyle in Emerging Economies
  • Introduction of Biomaterials in Cancer Research

Key Companies Profiled

BASF SE, Carpenter Technology Corporation, Celanese Corporation, Collagen Solutions Plc, Corbion N.V., Covestro AG, DSM, Evonik Industries, Zimmer Biomet, Wright Medical Group N.V., Mitsubishi Chemical Holdings Corporation, Riton Biomaterial Co., Ltd., Berkeley Advanced Biomaterials Inc., BBS-Bioactive Bone Substitutes Oyj, Bioretec Ltd.

How This Report Can Add Value

Product / Innovation Strategy: The product segment helps the reader in understanding different types of product type (metal-based biomaterials, polymer-based biomaterials, ceramic-based biomaterials, natural-based biomaterials, inorganic glass-based biomaterials, radiopaque biomaterials, regenerative biomaterials, hybrid biomaterial combinations) associated with biomaterials. The report also includes a thorough qualitative and quantitative analysis of various application areas (cardiovascular, orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system, tissue engineering, and others). Additionally, the research also covers regional and country-wise analysis for different applications and product types in the biomaterials market.

Key Questions Answered in the Report:

  • What are the key drivers and challenges in the global biomaterials market?
  • How does the supply chain function in the global biomaterials market?
  • Which product type is expected to witness the maximum demand growth in the global biomaterials market during the period 2021-2031?
  • Which are the key application areas for which biomaterials may experience high demand during the forecast period 2021-2031?
  • Which are the key suppliers of biomaterials in different countries and regions?
  • How is the industry expected to evolve during the forecast period 2021-2031?
  • What are the key offerings of the prominent manufacturers in the global biomaterials market?
  • Which regions and countries are leading in terms of consumption of biomaterials, and which of them are expected to witness high demand growth from 2021 to 2031?
  • What are the key consumer attributes in various countries in the global biomaterials market?
  • Which are the major patents filed in the biomaterials space?
  • What are the key developmental strategies implemented by the key players to sustain the competitive market?
  • What is the competitive strength of the key players in the global biomaterials market based on their recent developments, product offerings, and regional presence?
  • Who are the key players (along with their detailed analysis and profiles, including their company snapshots, key products and services, and strength and weakness analysis) in the market?

Biomaterials Market

The history of biomaterials dates from 4000 years when the ancient Egyptians used wires of linen to close the wound. In the Middle Ages, the Europeans used sutures made of catgut. Inca surgeons also used golden dishes to repair cranial fractures, and the ancient Maya used shells to create artificial teeth. In 200 AD, Europeans also produced artificial iron teeth. However, these materials were not completely compatible and organic with the human body.

Biomaterials Industry Overview

The biomaterials market is majorly segmented by application, product type, and region. The major categories product by type includes metal-based biomaterials, polymer-based biomaterials, ceramic-based biomaterials, natural-based biomaterials, inorganic glass-based biomaterials, radiopaque biomaterials, regenerative biomaterials, hybrid biomaterial combinations. Moreover, the major applications include cardiovascular, orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), tissue engineering, and others. By region, the global biomaterials are segmented into North America, Europe, Asia-Pacific, China, U.K., and Rest-of-the-World.

The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031. The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing funds/aids by the government for research purposes, increasing wound healing therapies & plastic surgeries, increasing aging/geriatric population, rise in prevalence of cardiovascular diseases, increasing awareness of regenerative medicine, increasing orthopedic disorders, and growing demand for implantable devices. However, biocompatibility issues, stringent safety regulations, and limitations of biomaterial-based products are hampering the growth of the biomaterials market. Increasing obesity, the introduction of biomaterials in cancer research, and increasing patient awareness and improved lifestyle in growing economies such as India, China, and South Korea are expected to create opportunities in the biomaterials market.

Market Segmentation

Biomaterials Market by Application

Among different biomaterials applications, cardiovascular dominates the market and is expected to be the largest application during the forecast period. The growing use of biomaterials in the cardiovascular application segment is majorly subjected to its biocompatibility as biomaterials come in contact with blood, vascular endothelial cells, fibroblasts, and myocardium, as well as a number of other cells and a cellular matrix material. Biomaterials that are used in the cardiovascular system include materials such as metals and polymers. The use of biomaterials in the cardiovascular system can be classified as temporary internal, temporary external, and permanent internal devices.

Biomaterials Market by Product

Among different biomaterials product type metal-based biomaterials dominates the market and is expected to be the largest product type during the forecast period. The dominance of metal-based biomaterials is attributed to wide use in the applications of biomaterials such as cardiovascular, orthopedic, ophthalmology, dental. From simple wires, rods, pins, screws to fracture fixation plates and total joint prostheses (artificial joints) for hips, knees, shoulders, and ankles, metals are used in all applications, including maxillofacial surgery, cardiovascular surgery, and dental materials, etc. The metal-based biomaterials include stainless steel, commercially pure titanium and titanium alloys, cobalt and chromium alloys, gold, silver, magnesium, and nitinol.

Biomaterials Market by Region

The demand for biomaterials varies according to various regions. The biomaterials market holds a prominent share in various countries of North America, Asia-Pacific and Japan, Europe, the U.K., China, and Rest-of-the-World, among which North America is expected to be the largest region for the global biomaterials market during the forecast period. Industrial advancements, extensive investments for dedicated R&D facilities, and the development of different application products that require biomaterials are some of the major drivers that are currently propelling the growth of the North America biomaterials market. Additionally, due to the wide-scale production of biomaterials as well as technological advancements pertaining to the technology, the global market for biomaterials is expected to grow at a steady rate.

Key Market Players and Competition Synopsis

BASF SE, Carpenter Technology Corporation, Celanese Corporation, Collagen Solutions Plc, Corbion N.V., Covestro AG, DSM, Evonik Industries, Zimmer Biomet, Wright Medical Group N.V., Mitsubishi Chemical Holdings Corporation, Riton Biomaterial Co., Ltd., Berkeley Advanced Biomaterials Inc., BBS-Bioactive Bone Substitutes Oyj, Bioretec Ltd.

The companies that are profiled in the report have been selected based on a selective pool of players, primarily Tier-1 (holding 50-60% of the market) and mid-segment players (comprising 30-40% share), and small and emerging companies (holding the balance 10-20% share), based on various factors such as product portfolios, annual revenues, market penetrations, research, and development initiatives, along with a domestic and international presence in the biomaterials industry.

Table of Contents
Product Code: MCB0488SB

Table of Contents

1 Markets

  • 1.1 Industry Outlook
    • 1.1.1 Trends: Current and Future
    • 1.1.2 Supply Chain Network
    • 1.1.3 Industry Attractiveness
      • 1.1.3.1 Threat of New Entrants (Moderate)
      • 1.1.3.2 Bargaining Power of Buyers (Moderate)
      • 1.1.3.3 Bargaining Power of Suppliers (Moderate)
      • 1.1.3.4 Threat of Substitutes (Low)
      • 1.1.3.5 Intensity of Competitive Rivalry (High)
    • 1.1.4 Patent Analysis
      • 1.1.4.1 Patent Analysis (by Status)
      • 1.1.4.2 Patent Analysis (by Organization)
  • 1.2 Market Dynamics
    • 1.2.1 Market Driver
      • 1.2.1.1 Increasing Funds/Aids by Government for Research Purposes
      • 1.2.1.2 Increasing Plastic Surgery and Wound Healing Therapies
      • 1.2.1.3 Increasing Aging/Geriatric Population
      • 1.2.1.4 Rise in Prevalence of Cardiovascular Diseases
      • 1.2.1.5 Increasing Orthopedic Disorders
      • 1.2.1.6 Growing Demand for Implantable Devices
      • 1.2.1.7 Increasing Awareness of Regenerative Medicine
    • 1.2.2 Market Restraint
      • 1.2.2.1 Biocompatibility Issues and Safety and Stringent Regulations
      • 1.2.2.2 Limitations of Biomaterial-Based Products
    • 1.2.3 Market Opportunity
      • 1.2.3.1 Increasing Obesity
      • 1.2.3.2 Patient Awareness and Improved Lifestyle in Emerging Economies
      • 1.2.3.3 Introduction of Biomaterials in Cancer Research
    • 1.2.4 Business and Corporate Strategies
      • 1.2.4.1 Key Market Development and Strategies
      • 1.2.4.2 Product Launches and Developments
      • 1.2.4.3 Partnerships, Collaborations, and Contracts
      • 1.2.4.4 Business Expansions
      • 1.2.4.5 Mergers, Acquisitions, and Joint Ventures
      • 1.2.4.6 Other Key Developments

2 Application

  • 2.1 Global Biomaterials Market (by Application, Sub-Application and Specification)
  • 2.2 Demand Analysis of Global Biomaterials Market (by Application and Sub-Application), Value and Volume Data
    • 2.2.1 Cardiovascular
      • 2.2.1.1 Catheters
      • 2.2.1.2 Stents
      • 2.2.1.3 Heart Valves
      • 2.2.1.4 Guidewires
      • 2.2.1.5 Sensors
      • 2.2.1.6 Pacemaker
      • 2.2.1.7 Implantable Cardiac Defibrillators (ICD)
      • 2.2.1.8 Vascular Grafts
    • 2.2.2 Orthopedic
      • 2.2.2.1 Joint Replacement
        • 2.2.2.1.1 Hip Replacement
        • 2.2.2.1.2 Knee Replacement
        • 2.2.2.1.3 Shoulder Replacement
        • 2.2.2.1.4 Other Replacement
      • 2.2.2.2 Viscos Supplementation
      • 2.2.2.3 Bioresorbable Tissue Fixation
        • 2.2.2.3.1 Suture Anchors
        • 2.2.2.3.2 Interference Screws
        • 2.2.2.3.3 Meshes
      • 2.2.2.4 Spine
        • 2.2.2.4.1 Minimally Invasive Fusion Surgeries
        • 2.2.2.4.2 Motion Preservation and Dynamic Stabilization
          • 2.2.2.4.2.1 Pedicle-Based-Rod Systems
          • 2.2.2.4.2.2 Interspinous Spacers
          • 2.2.2.4.2.3 Disc Arthroplasty/Replacement
      • 2.2.2.5 Fracture Fixation
        • 2.2.2.5.1 Bone Plates
        • 2.2.2.5.2 Screws
        • 2.2.2.5.3 Pins
        • 2.2.2.5.4 Rods
      • 2.2.2.6 Fracture Fixation
        • 2.2.2.6.1 Bone Grafts
    • 2.2.3 Ophthalmology
      • 2.2.3.1 Contact Lenses
      • 2.2.3.2 Intraocular Lenses
      • 2.2.3.3 Functional Replacement of Ocular Tissues
      • 2.2.3.4 Synthetic Corneas
      • 2.2.3.5 Others
    • 2.2.4 Dental
      • 2.2.4.1 Dental Bone Grafts and Substitutes
      • 2.2.4.2 Dental Membranes
    • 2.2.5 Wound Healing
      • 2.2.5.1 Wound Closure Devices
      • 2.2.5.2 Sutures
      • 2.2.5.3 Staples
      • 2.2.5.4 Surgical Hemostats
      • 2.2.5.5 Internatal Tissue Sealants
      • 2.2.5.6 Adhesion Barriers
      • 2.2.5.7 Hernia Meshes
    • 2.2.6 Plastic Surgery
      • 2.2.6.1 Soft Tissue Fillers
      • 2.2.6.2 Craniofacial Surgery
    • 2.2.7 Neurological/Central Nervous System
      • 2.2.7.1 Shunting Systems
      • 2.2.7.2 Cortical Neural Prosthetics (CNP)
      • 2.2.7.3 Hydrogel Scaffolds for CNS Report
      • 2.2.7.4 Neural Stem Cell Encapsulation
    • 2.2.8 Tissue Engineering
      • 2.2.8.1 Scaffolds for Regenerative Medicine
      • 2.2.8.2 Nanomaterial for Biosensing
      • 2.2.8.3 Tailoring of Inorganic Nanoparticles
    • 2.2.9 Others
      • 2.2.9.1 Drug Delivery Systems
      • 2.2.9.2 Gastrointestinal Applications
      • 2.2.9.3 Bariatric Surgery
      • 2.2.9.4 Urinary Applications

3 Products

  • 3.1 Global Biomaterials Market (by Product Type, Sub-Product Type and Specifications)
  • 3.2 Demand Analysis of Global Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
    • 3.2.1 Metal-Based Biomaterials
      • 3.2.1.1 Stainless Steel
      • 3.2.1.2 Titanium and Titanium alloys
      • 3.2.1.3 Cobalt-Chromium (Co-Cr) Alloys
      • 3.2.1.4 Magnesium (Mg)
      • 3.2.1.5 Gold (Au)
      • 3.2.1.6 Silver (Ag)
      • 3.2.1.7 Nitinol
      • 3.2.1.8 Other Metal-Based Biomaterials
    • 3.2.2 Polymer-Based Biomaterials
      • 3.2.2.1 Polyethylene Terephthalate (PET)
      • 3.2.2.2 Polypropylene (PP)
      • 3.2.2.3 Polyetheretherketone (PEEK)
      • 3.2.2.4 Ultra-High Molecular Weight Polyethylene (UHMWPE)
      • 3.2.2.5 Polytetrafluoroethylene (PTFE)
      • 3.2.2.6 Polyglycolide (PGA)
      • 3.2.2.7 Polyactide (PLA)
      • 3.2.2.8 Polycaprolactone (PCL)
      • 3.2.2.9 Polyglycerol Sebacate (PGS)
      • 3.2.2.10 Polyvinylchloride (PVC)
      • 3.2.2.11 Silicone Rubber
      • 3.2.2.12 Nylon
      • 3.2.2.13 Polymethyl Methacrylate (PMMA)
      • 3.2.2.14 Other Polymer-Based Biomaterials
    • 3.2.3 Ceramic-Based Biomaterials
      • 3.2.3.1 Alumina
      • 3.2.3.2 Calcium Phosphate
      • 3.2.3.3 Zirconia
      • 3.2.3.4 Calcium Sulfate
      • 3.2.3.5 Carbon
      • 3.2.3.6 Other Ceramic-Based Biomaterials
    • 3.2.4 Natural-Based Biomaterials
      • 3.2.4.1 Collagen
      • 3.2.4.2 Fibrin
      • 3.2.4.3 Gelatin
      • 3.2.4.4 Silk
      • 3.2.4.5 Alginates
      • 3.2.4.6 Hyaluronic Acid
      • 3.2.4.7 Chitin and Chitosan
      • 3.2.4.8 Cellulose
    • 3.2.5 Inorganic Glass-Based Biomaterials
      • 3.2.5.1 Silicates
      • 3.2.5.2 Bioactive Glass
      • 3.2.5.3 Phosphate
    • 3.2.6 Radiopaque Biomaterials
    • 3.2.7 Regenerative Biomaterials
    • 3.2.8 Hybrid Biomaterial Combinations

4 Region

  • 4.1 North America
    • 4.1.1 Market
      • 4.1.1.1 Key Manufacturers and Suppliers in North America
      • 4.1.1.2 Business Drivers
      • 4.1.1.3 Business Challenges
    • 4.1.2 Applications
      • 4.1.2.1 North America Biomaterials Market (by Application and Sub-Application), Value and Volume Data
    • 4.1.3 Product
      • 4.1.3.1 North America Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
    • 4.1.4 North America (by Country)
      • 4.1.4.1 U.S.
        • 4.1.4.1.1 Market
          • 4.1.4.1.1.1 Buyer Attributes
          • 4.1.4.1.1.2 Key Manufacturers and Suppliers in the U.S.
          • 4.1.4.1.1.3 Business Challenges
          • 4.1.4.1.1.4 Business Drivers
        • 4.1.4.1.2 Application
          • 4.1.4.1.2.1 U.S. Biomaterials Market (by Application and Sub-Application)
        • 4.1.4.1.3 Product
          • 4.1.4.1.3.1 U.S. Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.1.4.2 Canada
        • 4.1.4.2.1 Market
          • 4.1.4.2.1.1 Buyer Attributes
          • 4.1.4.2.1.2 Key Manufacturers and Suppliers in Canada
          • 4.1.4.2.1.3 Business Challenges
          • 4.1.4.2.1.4 Business Drivers
        • 4.1.4.2.2 Application
          • 4.1.4.2.2.1 Canada Biomaterials Market (by Application and Sub-Application)
        • 4.1.4.2.3 Product
          • 4.1.4.2.3.1 Canada Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.1.4.3 Mexico
          • 4.1.4.3.1.1 Buyer Attributes
          • 4.1.4.3.1.2 Key Manufacturers and Suppliers in Mexico
          • 4.1.4.3.1.3 Business Challenges
          • 4.1.4.3.1.4 Business Drivers
        • 4.1.4.3.2 Application
          • 4.1.4.3.2.1 Mexico Biomaterials Market (by Application and Sub-Application)
        • 4.1.4.3.3 Product
          • 4.1.4.3.3.1 Mexico Biomaterials Market (by Product Type and Sub-Product Type)
  • 4.2 Europe
    • 4.2.1 Market
      • 4.2.1.1 Key Manufacturers and Suppliers in Europe
      • 4.2.1.2 Business Drivers
      • 4.2.1.3 Business Challenges
    • 4.2.2 Applications
      • 4.2.2.1 Europe Biomaterials Market (by Application and Sub-Application), Value and Volume Data
    • 4.2.3 Product
      • 4.2.3.1 Europe Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
    • 4.2.4 Europe (by Country)
      • 4.2.4.1 Germany
        • 4.2.4.1.1 Market
          • 4.2.4.1.1.1 Buyer Attributes
        • 4.2.4.1.2 Key Manufacturers and Suppliers in Germany
        • 4.2.4.1.3 Business Challenges
        • 4.2.4.1.4 Business Drivers
        • 4.2.4.1.5 Application
          • 4.2.4.1.5.1 Germany Biomaterials Market (by Application and Sub-Application)
        • 4.2.4.1.6 Product
          • 4.2.4.1.6.1 Germany Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.2.4.2 France
        • 4.2.4.2.1 Market
          • 4.2.4.2.1.1 Buyer Attributes
          • 4.2.4.2.1.2 Key Manufacturers and Suppliers in France
          • 4.2.4.2.1.3 Business Challenges
          • 4.2.4.2.1.4 Business Drivers
        • 4.2.4.2.2 Application
          • 4.2.4.2.2.1 France Biomaterials Market (by Application and Sub-application)
        • 4.2.4.2.3 Product
          • 4.2.4.2.3.1 France Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.2.4.3 Spain
        • 4.2.4.3.1 Market
          • 4.2.4.3.1.1 Buyer Attributes
          • 4.2.4.3.1.2 Key Manufacturers and Suppliers in Spain
          • 4.2.4.3.1.3 Business Challenges
          • 4.2.4.3.1.4 Business Drivers
        • 4.2.4.3.2 Application
          • 4.2.4.3.2.1 Spain Biomaterials Market (by Application and Sub-Application)
        • 4.2.4.3.3 Product
          • 4.2.4.3.3.1 Spain Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.2.4.4 Italy
        • 4.2.4.4.1 Market
          • 4.2.4.4.1.1 Buyer Attributes
          • 4.2.4.4.1.2 Key Manufacturers and Suppliers in Italy
          • 4.2.4.4.1.3 Business Challenges
          • 4.2.4.4.1.4 Business Drivers
        • 4.2.4.4.2 Application
          • 4.2.4.4.2.1 Italy Biomaterials Market (by Application and Sub-Application)
        • 4.2.4.4.3 Product
          • 4.2.4.4.3.1 Italy Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.2.4.5 Russia
        • 4.2.4.5.1 Market
          • 4.2.4.5.1.1 Buyer Attributes
          • 4.2.4.5.1.2 Key Manufacturers and Suppliers in Russia
          • 4.2.4.5.1.3 Business Challenges
          • 4.2.4.5.1.4 Business Drivers
        • 4.2.4.5.2 Application
          • 4.2.4.5.2.1 Russia Biomaterials Market (by Application and Sub-Application)
        • 4.2.4.5.3 Product
          • 4.2.4.5.3.1 Russia Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.2.4.6 Rest-of-Europe
        • 4.2.4.6.1 Application
          • 4.2.4.6.1.1 Rest-of-Europe Biomaterials Market (by Application and Sub-Application)
        • 4.2.4.6.2 Product
          • 4.2.4.6.2.1 Rest-of-Europe Biomaterials Market (by Product Type and Sub-Product Type)
  • 4.3 U.K.
    • 4.3.1 Market
      • 4.3.1.1 Buyer Attributes
      • 4.3.1.2 Key Manufacturers and Suppliers in the U.K.
      • 4.3.1.3 Business Challenges
      • 4.3.1.4 Business Drivers
    • 4.3.2 Applications
      • 4.3.2.1 U.K. Biomaterials Market (by Application and Sub-Application)
    • 4.3.3 Product
      • 4.3.3.1 U.K. Biomaterials Market (by Product Type and Sub-Product Type)
  • 4.4 China
    • 4.4.1 Market
      • 4.4.1.1 Buyer Attributes
      • 4.4.1.2 Key Manufacturers and Suppliers in China
      • 4.4.1.3 Business Challenges
      • 4.4.1.4 Business Drivers
    • 4.4.2 Applications
      • 4.4.2.1 China Biomaterials Market (by Application and Sub-Application)
    • 4.4.3 Product
      • 4.4.3.1 China Biomaterials Market (by Product Type and Sub-Product Type)
  • 4.5 Asia-Pacific and Japan
    • 4.5.1 Market
      • 4.5.1.1 Key Manufacturers and Suppliers in Asia-Pacific and Japan
      • 4.5.1.2 Business Drivers
      • 4.5.1.3 Business Challenges
    • 4.5.2 Applications
      • 4.5.2.1 Asia-Pacific & Japan Biomaterials Market (by Application and Sub-Application), Value and Volume Data
    • 4.5.3 Product
      • 4.5.3.1 Asia-Pacific & Japan Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
    • 4.5.4 Asia-Pacific (by Country)
      • 4.5.4.1 Japan
    • 4.5.5 Market
      • 4.5.5.1 Buyer Attributes
      • 4.5.5.2 Key Manufacturers and Suppliers in Japan
      • 4.5.5.3 Business Challenges
      • 4.5.5.4 Business Drivers
        • 4.5.5.4.1 Application
          • 4.5.5.4.1.1 Japan Biomaterials Market (by Application and Sub-Application)
        • 4.5.5.4.2 Product
          • 4.5.5.4.2.1 Japan Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.5.5.2 South Korea
    • 4.5.6 Market
      • 4.5.6.1 Buyer Attributes
      • 4.5.6.2 Key Manufacturers and Suppliers in South Korea
      • 4.5.6.3 Business Challenges
      • 4.5.6.4 Business Drivers
        • 4.5.6.4.1 Application
          • 4.5.6.4.1.1 South Korea Biomaterials Market (by Application and Sub-Application)
        • 4.5.6.4.2 Product
          • 4.5.6.4.2.1 South Korea Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.5.6.5 India
    • 4.5.7 Market
      • 4.5.7.1 Buyer Attributes
      • 4.5.7.2 Key Manufacturers and Suppliers in India
      • 4.5.7.3 Business Challenges
      • 4.5.7.4 Business Drivers
        • 4.5.7.4.1 Application
          • 4.5.7.4.1.1 India Biomaterials Market (by Application and Sub-Application)
        • 4.5.7.4.2 Product
          • 4.5.7.4.2.1 India Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.5.7.5 Rest-of-Asia-Pacific
        • 4.5.7.5.1 Application
          • 4.5.7.5.1.1 Rest-of-Asia-Pacific Biomaterials Market (by Application and Sub-Application)
        • 4.5.7.5.2 Product
          • 4.5.7.5.2.1 Rest-of-Asia-Pacific Biomaterials Market (by Product Type and Sub-Product Type)
  • 4.6 Rest-of-the-World
    • 4.6.1 Market
      • 4.6.1.1 Key Manufacturers and Suppliers in Rest-of-the-World
      • 4.6.1.2 Business Drivers
      • 4.6.1.3 Business Challenges
    • 4.6.2 Applications
      • 4.6.2.1 Rest-of-the-World Biomaterials Market (by Application and Sub-Application), Value and Volume Data
    • 4.6.3 Product
      • 4.6.3.1 Rest-of-the-World Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
      • 4.6.3.2 South America
    • 4.6.4 Market
      • 4.6.4.1 Buyer Attributes
      • 4.6.4.2 Key Manufacturers and Suppliers in South America
      • 4.6.4.3 Business Challenges
      • 4.6.4.4 Business Drivers
        • 4.6.4.4.1 Application
          • 4.6.4.4.1.1 South America Biomaterials Market (by Application and Sub-Application)
        • 4.6.4.4.2 Product
          • 4.6.4.4.2.1 South America Biomaterials Market (by Product Type and Sub-Product Type)
      • 4.6.4.5 Middle East and Africa
    • 4.6.5 Market
      • 4.6.5.1 Buyer Attributes
      • 4.6.5.2 Key Manufacturers and Suppliers in Middle East and Africa
      • 4.6.5.3 Business Challenges
      • 4.6.5.4 Business Drivers
        • 4.6.5.4.1 Application
          • 4.6.5.4.1.1 Middle East and Africa Biomaterials Market (by Application and Sub-Application)
        • 4.6.5.4.2 Product
          • 4.6.5.4.2.1 Middle East and Africa Biomaterials Market (by Product Type and Sub-Product Type)

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Competitive Benchmarking
  • 5.2 Company Profiles
    • 5.2.1 BASF SE
      • 5.2.1.1 Company Overview
      • 5.2.1.2 Product Portfolio
      • 5.2.1.3 Corporate Strategies
      • 5.2.1.4 Production Sites and R&D Analysis
      • 5.2.1.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.1.6 Weakness of the Company in the Global Biomaterials Market
    • 5.2.2 Carpenter Technology Corporation
      • 5.2.2.1 Company Overview
      • 5.2.2.2 Product Portfolio
      • 5.2.2.3 Corporate Strategies
      • 5.2.2.4 Production Sites and R&D Analysis
      • 5.2.2.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.2.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.3 Celanese Corporation
      • 5.2.3.1 Company Overview
      • 5.2.3.2 Product Portfolio
      • 5.2.3.3 Corporate Strategies
      • 5.2.3.4 Production Sites and R&D Analysis
      • 5.2.3.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.3.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.4 Collagen Solutions Plc
      • 5.2.4.1 Company Overview
      • 5.2.4.2 Product Portfolio
      • 5.2.4.3 Corporate Strategies
      • 5.2.4.4 Strengths of the Company in the Global Biomaterials Market
      • 5.2.4.5 Weakness of the Company in the Global Biomaterials Market
    • 5.2.5 Corbion N.V.
      • 5.2.5.1 Company Overview
      • 5.2.5.2 Product Portfolio
      • 5.2.5.3 Corporate Strategies
      • 5.2.5.4 Production Sites and R&D Analysis
      • 5.2.5.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.5.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.6 Covestro AG
      • 5.2.6.1 Company Overview
      • 5.2.6.2 Product Portfolio
      • 5.2.6.3 Corporate Strategies
      • 5.2.6.4 Production Sites and R&D Analysis
      • 5.2.6.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.6.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.7 DSM
      • 5.2.7.1 Company Overview
      • 5.2.7.2 Product Portfolio
      • 5.2.7.3 Corporate Strategies
      • 5.2.7.4 Production Sites and R&D Analysis
      • 5.2.7.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.7.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.8 Evonik Industries
      • 5.2.8.1 Company Overview
      • 5.2.8.2 Product Portfolio
      • 5.2.8.3 Corporate Strategies
      • 5.2.8.4 Production Sites and R&D Analysis
      • 5.2.8.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.8.6 Weakness of the Company in the Global Biomaterials Market
    • 5.2.9 Zimmer Biomet
      • 5.2.9.1 Company Overview
      • 5.2.9.2 Product Portfolio
      • 5.2.9.3 Corporate Strategies
      • 5.2.9.4 Production Sites and R&D Analysis
      • 5.2.9.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.9.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.10 Wright Medical Group N.V.
      • 5.2.10.1 Company Overview
      • 5.2.10.2 Product Portfolio
      • 5.2.10.3 Corporate Strategies
      • 5.2.10.4 Strength of the Company in the Global Biomaterials Market
      • 5.2.10.5 Weakness of the Company in the Global Biomaterials Market
    • 5.2.11 Mitsubishi Chemical Holdings Corporation.
      • 5.2.11.1 Company Overview
      • 5.2.11.2 Product Portfolio
      • 5.2.11.3 Corporate Strategies
      • 5.2.11.4 Production Sites and R&D Analysis
      • 5.2.11.5 Strengths of the Company in the Global Biomaterials Market
      • 5.2.11.6 Weaknesses of the Company in the Global Biomaterials Market
    • 5.2.12 Riton Biomaterial Co., Ltd.
      • 5.2.12.1 Company Overview
      • 5.2.12.2 Product Portfolio
      • 5.2.12.3 Strength of the Company in the Global Biomaterials Market
      • 5.2.12.4 Weakness of the Company in the Global Biomaterials Market
    • 5.2.13 Berkeley Advanced Biomaterials Inc.
      • 5.2.13.1 Company Overview
      • 5.2.13.2 Product Portfolio
      • 5.2.13.3 Strength of the Company in the Global Biomaterials Market
      • 5.2.13.4 Weakness of the Company in the Global Biomaterials Market
    • 5.2.14 BBS-Bioactive Bone Substitutes Oyj
      • 5.2.14.1 Company Overview
      • 5.2.14.2 Product Portfolio
      • 5.2.14.3 Corporate Strategies
      • 5.2.14.4 Strength of the Company in the Global Biomaterials Market
      • 5.2.14.5 Weakness of the Company in the Global Biomaterials Market
    • 5.2.15 Bioretec Ltd.
      • 5.2.15.1 Company Overview
      • 5.2.15.2 Product Portfolio
      • 5.2.15.3 Corporate Strategies
      • 5.2.15.4 Strength of the Company in the Global Biomaterials Market
      • 5.2.15.5 Weakness of the Company in the Global Biomaterials Market

6 Research Methodology

List of Figures

  • Figure 1: Global Biomaterials Market Snapshot, 2020, 2021 and 2031
  • Figure 2: Global Biomaterials Market (by Product Type)
  • Figure 3: Global Biomaterials Market (by Region), $Billion, 2021 and 2031
  • Figure 4: Global Biomaterials Market: Coverage
  • Figure 5: Supply Chain Analysis of Global Biomaterials Market
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Year-Wise Patents Filed in Global Biomaterials Market, January 2018-August 2021
  • Figure 8: Patent Analysis (by Status), January 2018-August 2021
  • Figure 9: Patent Analysis (by Organization), January 2018-August 2021
  • Figure 10: Market Dynamics: Global Biomaterials Market
  • Figure 11: Number of Plastic Surgery Procedures (by Country), 2019
  • Figure 12: Leading Causes of Deaths by American Heart Association
  • Figure 13: Total Developments of Biomaterials (2018-2021)
  • Figure 14: Competitive Benchmarking Matrix
  • Figure 15: R&D Expenditure of BASF SE, 2019-2020
  • Figure 16: R&D Expenditure of Carpenter Technology Corporation, 2018-2020
  • Figure 17: R&D Expenditure of Celanese Corporation, 2018-2020
  • Figure 18: R&D Expenditure of Corbion N.V., 2019-2020
  • Figure 19: R&D Expenditure of Covestro AG, 2019-2020
  • Figure 20: R&D Expenditure of DSM, 2019-2020
  • Figure 21: R&D Expenditure of Evonik Industries, 2018-2020
  • Figure 22: R&D Expenditure of Zimmer Biomet, 2019-2020
  • Figure 23: R&D Expenditure of Mitsubishi Chemical Holdings Corporation, 2019-2020
  • Figure 24: Research Methodology
  • Figure 25: Top-Down and Bottom-Up Approach
  • Figure 26: Assumptions and Limitations

List of Tables

  • Table 1: Global Biomaterials Market (by Application)
  • Table 2: Key Factor in Determining "Threat of New Entrants" in Biomaterials Market
  • Table 3: Key Factor in Determining "Bargaining Power of Buyers" in Biomaterials Market
  • Table 4: Key Factor in Determining "Bargaining Power of Suppliers" in Biomaterials Market
  • Table 5: Key Factor in Determining "Threat of Substitutes" in Biomaterials Market
  • Table 6: Key Factor in Determining "Intensity of Competitive Rivalry" in Biomaterials Market
  • Table 7: Impact Analysis of Driver
  • Table 8: Global Aging Population
  • Table 9: Impact Analysis of Restraint
  • Table 10: Impact Analysis of Opportunity
  • Table 11: Key Product Launch and Development Activities (2018-2021)
  • Table 12: Key Partnerships, Collaborations, and Contracts (2018-2021)
  • Table 13: Key Business Expansion Activities (2018-2021)
  • Table 14: Key Mergers, Acquisitions, and Joint Ventures (2018-2021)
  • Table 15: Other Key Developments (2018-2021)
  • Table 16: Global Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 17: Global Biomaterials Market (by Application), Kilo Ton, 2020 -2031
  • Table 18: Global Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 19: Global Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
  • Table 20: North America Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 21: North America Biomaterials Market (by Application), Kilo Ton, 2020-2031
  • Table 22: North America Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 23: North America Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
  • Table 24: U.S. Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 25: U.S. Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 26: Canada Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 27: Canada Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 28: Mexico Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 29: Mexico Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 30: Europe Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 31: Europe Biomaterials Market (by Application), Kilo Ton, 2020-2031
  • Table 32: Europe Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 33: Europe Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
  • Table 34: Germany Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 35: Germany Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 36: France Biomaterials Market (by Application and Sub-application), $Billion, 2020-2031
  • Table 37: France Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 38: Spain Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 39: Spain Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 40: Italy Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 41: Italy Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 42: Russia Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 43: Russia Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 44: Rest-of-Europe Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 45: Rest-of-Europe Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 46: U.K. Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 47: U.K. Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 48: China Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 49: China Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 50: Asia-Pacific & Japan Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 51: Asia-Pacific & Japan Biomaterials Market (by Application), Kilo Ton, 2020-2031
  • Table 52: Asia-Pacific & Japan Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 53: Asia-Pacific & Japan Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
  • Table 54: Japan Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 55: Japan Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 56: South Korea Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 57: South Korea Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 58: India Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 59: India Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 60: Rest-of-Asia-Pacific Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 61: Rest-of-Asia-Pacific Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 62: Rest-of-the-World Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 63: Rest-of-the-World Biomaterials Market (by Application), Kilo Ton, 2020-2031
  • Table 64: Rest-of-the-World Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 65: Rest-of-the-World Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
  • Table 66: South America Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 67: South America Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
  • Table 68: Middle East and Africa Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
  • Table 69: Middle East and Africa Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031